BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15320722)

  • 1. Chemistry-based design of inhibitors for carboxypeptidase A.
    Kim DH
    Curr Top Med Chem; 2004; 4(12):1217-26. PubMed ID: 15320722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel strategy for designing irreversible inhibitors of metalloproteases: acetals as latent electrophiles that interact with catalytic nucleophile at the active site.
    Han MS; Ryu CH; Chung SJ; Kim DH
    Org Lett; 2000 Oct; 2(20):3149-52. PubMed ID: 11009368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational investigation of irreversible inactivation of the zinc-dependent protease carboxypeptidase A.
    Cross JB; Vreven T; Meroueh SO; Mobashery S; Schlegel HB
    J Phys Chem B; 2005 Mar; 109(10):4761-9. PubMed ID: 16851559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible inhibition of zinc-containing protease by oxazolidinone derivatives. Novel inactivation chemistry.
    Kim DH; Chung SJ; Kim EJ; Tian GR
    Bioorg Med Chem Lett; 1998 Apr; 8(7):859-64. PubMed ID: 9871555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insight into the inactivation of carboxypeptidase A by alpha-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity.
    Chung SJ; Chung S; Lee HS; Kim EJ; Oh KS; Choi HS; Kim KS; Kim YJ; Hahn JH; Kim DH
    J Org Chem; 2001 Sep; 66(19):6462-71. PubMed ID: 11559199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A.
    Park JD; Kim DH
    Bioorg Med Chem; 2004 May; 12(9):2349-56. PubMed ID: 15080932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of an effective mechanism-based inactivator for a zinc protease.
    Mobashery S; Ghosh SS; Tamura SY; Kaiser ET
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):578-82. PubMed ID: 2300547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of alpha-nitromethyl ketone as a new zinc-binding group based on structural analysis of its complex with carboxypeptidase A.
    Wang SF; Tian GR; Zhang WZ; Jin JY
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5009-11. PubMed ID: 19646864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A.
    Ghosh SS; Dakoji S; Tanaka Y; Cho YJ; Mobashery S
    Bioorg Med Chem; 1996 Sep; 4(9):1487-92. PubMed ID: 8894106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new inhibitor design strategy for carboxypeptidase A as exemplified by N-(2-chloroethyl)-N-methylphenylalanine.
    Park JD; Lee KJ; Kim DH
    Bioorg Med Chem; 2001 Feb; 9(2):237-43. PubMed ID: 11249116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a mechanism for reactive inhibition of carboxypeptidase A with QM/MM methods.
    Phoon L; Burton NA
    J Mol Graph Model; 2005 Oct; 24(2):94-101. PubMed ID: 16144767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway.
    Lee KJ; Kim DH
    Bioorg Med Chem; 1998 Sep; 6(9):1613-22. PubMed ID: 9801832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
    Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
    J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based inhibition of zinc proteases.
    Kim DH; Mobashery S
    Curr Med Chem; 2001 Jul; 8(8):959-65. PubMed ID: 11375763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The X-ray structure of carboxypeptidase A inhibited by a thiirane mechanism-based inhibitor.
    Fernández D; Testero S; Vendrell J; Avilés FX; Mobashery S
    Chem Biol Drug Des; 2010 Jan; 75(1):29-34. PubMed ID: 19895506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of alpha,alpha-disubstituted-3-mercaptopropanoic acids as inhibitors for carboxypeptidase A and implications with respect to enzyme inhibitor design.
    Lee HS; Kim DH
    Bioorg Med Chem; 2003 Nov; 11(22):4685-91. PubMed ID: 14556784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitro as a novel zinc-binding group in the inhibition of carboxypeptidase A.
    Wang SH; Wang SF; Xuan W; Zeng ZH; Jin JY; Ma J; Tian GR
    Bioorg Med Chem; 2008 Apr; 16(7):3596-601. PubMed ID: 18289863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphinic peptides as potent inhibitors of zinc-metalloproteases.
    Georgiadis D; Dive V
    Top Curr Chem; 2015; 360():1-38. PubMed ID: 25370521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gem-dialkyl succinic acids: a novel class of inhibitors for carboxypeptidases.
    Asante-Appiah E; Seetharaman J; Sicheri F; Yang DS; Chan WW
    Biochemistry; 1997 Jul; 36(29):8710-5. PubMed ID: 9220957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidic mechanism-based inactivators for carboxypeptidase A.
    Ghosh SS; Wu YQ; Mobashery S
    J Biol Chem; 1991 May; 266(14):8759-64. PubMed ID: 2026592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.